First-line autologous stem cell transplantation in primary CNS lymphoma

European Journal of Haematology

Volumn 75, Issue 4, 2005, Pages 288-292

  Brevet, M ^a   Garidi, R ^a   Gruson, B ^a   Royer, B ^a   Vaida, I ^a   Damaj, G ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

CNS; Lymphoma; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FOLINATE CALCIUM; IFOSFAMIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ALGODYSTROPHY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER REGRESSION; CANCER RELAPSE; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DYSESTHESIA; EPILEPSY; FOLLOW UP; HUMAN; IMMUNOCOMPETENCE; INFECTION; KIDNEY FAILURE; NEUROTOXICITY; NEUTROPENIA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; CYTARABINE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPETENCE; LYMPHOMA; MALE; MELPHALAN; MIDDLE AGED; NEUROTOXICITY SYNDROMES; RADIOTHERAPY, ADJUVANT; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 24744457735     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00508.x     Document Type: Article

References (18)

1. KHALFALLAH S, STAMATOULLAS A, FRUCHART C, et al. Durable remission of a relapsing primary central nervous system lymphoma after autologous bone marrow transplantation. Bone Marrow Transplant 1996;18:1021-1023.
2. ABREY LE, MOSKOWITZ CH, MASON WP, et al. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma. J Clin Oncol 2003;21:4151-4156.
3. SOUSSAIN C, SUZAN F, HOANG-XUAN K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001;19:742-749.
4. NELSON DF. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL). J Neurooncol 1999;43:241-247.
5. HOANG-XUAN K, TAILLANDIER L, CHINOT O, et al. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European organization for research and treatment of cancer brain tumor group. J Clin Oncol 2003;21:2726-2731.
6. GLASS J, GRUBER ML, CHER L, HOCHBERG FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long term outcome. J Neurosurg 1994;81:188-195.
7. ABREY LE, YAHALOM J, DE ANGELIS LM. Treatment for primary central nervous system lymphoma (PCNSL): the next step. J Clin Oncol 2000;18:3144-3150.
8. DEANGELIS LM, SEIFERHELD W, SCHULD SC, et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma. Radiation therapy oncology group study. J Clin Oncol 2002;20:4643-4648.
9. BLAY J-Y, CONROY T, CHEVREAU C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis and late neurologic toxicity in a retrospective series. J Clin Oncol 1998;16:864-871.
10. ABREY LE, DE ANGELIS LM, YAHALOM J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998;16:859-863.
11. MCLAUGHLIN P, VELASQUEZ WS, REDMAN JR, et al. Chemotherapy with dexamethasone, high-dose cytarabine and cisplatin for parenchymal brain lymphoma. J Natl Cancer Inst 1988;80:1408-1412.
12. CHAMBERLAIN MC, LEVIN VA. Adjuvant chemotherapy for primary lymphoma of the central nervous system. Arch Neurol 1990;47:1113-1116.
13. GABBAI AA, HOCHBERG FH, LINGGOOD RM, et al. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 1989;70:190-194.
14. MCALLISTER LD, DOOLITTLE ND, GUASTADISEGNI PE, et al. Cognitive outcomes and long-term follow-up after enhanced chemotherapy delivery for primary CNS lymphoma. Neurosurgery 2000;46:51-60.
15. NELSON DF, MARTZ KL, BONNER H, et al. Non-Hodgkin's lymphoma of the brain: can high-dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group (RTOG): RTOG: 8315. Int J Radiat Oncol Biol Phys 1992;23:9-17.
16. SANDOR V, STARK-VANCS V, PEARSON D, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998;16:3000-3006.
17. CHENG AL, YEH KH, UEN WC, et al. Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol. Cancer 1998;82:1946-1951.
18. CHER L, GLASS J, HARSH GR, HOCHBERG FH. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 1996;46:1757-1759.